Found: 97
Select item for more details and to access through your institution.
Medical Costs of Glaucoma and Ocular Hypertension in Italian Referral Centres: A Prospective Study.
- Published in:
- Ophthalmologica, 2007, v. 221, n. 5, p. 340, doi. 10.1159/000104765
- By:
- Publication type:
- Article
Direct Costs of Schizophrenia and Related Disorders in Italian Community Mental Health Services: A Multicenter, Prospective 1-Year Followup Study.
- Published in:
- Schizophrenia Bulletin, 2004, v. 30, n. 2, p. 295
- By:
- Publication type:
- Article
Pharmaceutical Patents in Europe: Radical Reforms Rather Than Getting Rid?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Integrated Care in Europe: Time to Get it Together?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
The Italian NHS: What Lessons to Draw from COVID-19?
- Published in:
- Applied Health Economics & Health Policy, 2020, v. 18, n. 4, p. 463, doi. 10.1007/s40258-020-00594-5
- By:
- Publication type:
- Article
Comment on: 'Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition'.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Pricing of HPV Vaccines in Europe: Back to the Future?
- Published in:
- Applied Health Economics & Health Policy, 2018, v. 16, n. 3, p. 275, doi. 10.1007/s40258-018-0375-9
- By:
- Publication type:
- Article
Multiple Criteria Decision Analysis in Health Technology Assessment for Drugs: Just Another Illusion?
- Published in:
- Applied Health Economics & Health Policy, 2018, v. 16, n. 1, p. 1, doi. 10.1007/s40258-017-0345-7
- By:
- Publication type:
- Article
Clinical Governance in Italy: 'Made in England' for Import?
- Published in:
- Applied Health Economics & Health Policy, 2017, v. 15, n. 5, p. 541, doi. 10.1007/s40258-017-0328-8
- By:
- Publication type:
- Article
'Appropriateness' in Italy: A 'Magic Word' in Pharmaceuticals?
- Published in:
- Applied Health Economics & Health Policy, 2017, v. 15, n. 1, p. 1, doi. 10.1007/s40258-016-0240-7
- By:
- Publication type:
- Article
Safety and Quality of Generic Drugs: A Never Ending Debate Fostered by Economic Interests?
- Published in:
- Applied Health Economics & Health Policy, 2015, v. 13, p. 3, doi. 10.1007/s40258-015-0156-7
- By:
- Publication type:
- Article
Biosimilar Versus Generic Drugs: Same But Different?
- Published in:
- Applied Health Economics & Health Policy, 2015, v. 13, n. 2, p. 125, doi. 10.1007/s40258-015-0154-9
- By:
- Publication type:
- Article
Comment on: 'Current Status and Trends in Performance-Based Risk-Sharing Arrangements Between Healthcare Payers and Medical Product Manufacturers'.
- Published in:
- Applied Health Economics & Health Policy, 2014, v. 12, n. 5, p. 565, doi. 10.1007/s40258-014-0118-5
- By:
- Publication type:
- Article
A Critical Systematic Review of Budget Impact Analyses on Drugs in the EU Countries.
- Published in:
- Applied Health Economics & Health Policy, 2014, v. 12, n. 1, p. 33, doi. 10.1007/s40258-013-0064-7
- By:
- Publication type:
- Article
Direct Cost of Medical Management of Epilepsy among Adults in Italy: A Prospective Cost-of-Illness Study (EPICOS).
- Published in:
- Epilepsia (Series 4), 2004, v. 45, n. 2, p. 171, doi. 10.1111/j.0013-9580.2004.14103.x
- By:
- Publication type:
- Article
Pain in primary care: an Italian survey.
- Published in:
- European Journal of Public Health, 2005, v. 15, n. 5, p. 475, doi. 10.1093/eurpub/cki033
- By:
- Publication type:
- Article
Tendering and value-based pricing: lessons from Italy on human papilloma virus vaccines.
- Published in:
- Journal of the Royal Society of Medicine, 2014, v. 107, n. 1, p. 4, doi. 10.1177/0141076813512122
- By:
- Publication type:
- Article
ECONOMIC EVALUATIONS IN ITALY: A REVIEW OF THE LITERATURE.
- Published in:
- International Journal of Technology Assessment in Health Care, 2003, v. 19, n. 4, p. 685, doi. 10.1017/S0266462303000643
- By:
- Publication type:
- Article
Modeling European health systems: an ideal chain of services.
- Published in:
- European Journal of Health Economics, 2024, v. 25, n. 2, p. 189, doi. 10.1007/s10198-023-01651-1
- By:
- Publication type:
- Article
General practice in the EU: countries you see, customs you find.
- Published in:
- European Journal of Health Economics, 2023, v. 24, n. 2, p. 153, doi. 10.1007/s10198-022-01549-4
- By:
- Publication type:
- Article
The Italian NHS at regional level: same in theory, different in practice.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Pricing vaccines and drugs in Europe: worth differentiating?
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Is it too expensive to fight cancer? Analysis of incremental costs and benefits of the Croatian National Plan Against Cancer.
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 3, p. 393, doi. 10.1007/s10198-020-01262-0
- By:
- Publication type:
- Article
Do European pharmacists really have to trespass on medicine?
- Published in:
- European Journal of Health Economics, 2021, v. 22, n. 1, p. 1, doi. 10.1007/s10198-020-01185-w
- By:
- Publication type:
- Article
More room for telemedicine after COVID-19: lessons for primary care?
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Correction to: Defensive medicine in Europe: a 'full circle'?
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Defensive medicine in Europe: a 'full circle'?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Defensive medicine in Europe: a 'full circle'?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Conflict of interest disclosure: striking a balance?
- Published in:
- 2019
- By:
- Publication type:
- Editorial
Pharmaceutical pricing conundrum: time to get rid of it?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Patient empowerment in Europe: is no further research needed?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Competition in pharmaceuticals: more product- than price-oriented?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Market approval for drugs in the EU: time to change direction?
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Reimbursable drug classes and ceilings in Italy: why not only one?
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Access to primary care in Italy: time for a shake-up?
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Western European markets for biosimilar and generic drugs: worth differentiating.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Italian risk-sharing agreements on drugs: are they worthwhile?
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Could co-payments on drugs help to make EU health care systems less open to political influence?
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Budget impact analysis in economic evaluation: a proposal for a clearer definition.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
To model or not to model: lessons from two vaccinations.
- Published in:
- 2011
- By:
- Publication type:
- Editorial
Health technology assessment: for whom the bell tolls?
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Should we really worry about “launch delays” of new drugs in OECD countries? Reply to J Cohen.
- Published in:
- European Journal of Health Economics, 2007, v. 8, n. 2, p. 171, doi. 10.1007/s10198-007-0056-3
- By:
- Publication type:
- Article
Should we really worry about "launch delays" of new drugs in OECD countries?
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Pharmaceutical policy in Italy.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Off-patent drugs in Italy.
- Published in:
- European Journal of Health Economics, 2006, v. 7, n. 1, p. 79, doi. 10.1007/s10198-005-0335-9
- By:
- Publication type:
- Article
Direct medical costs of monitoring and treating patients with Takayasu arteritis in Italy.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Direct medical costs unequivocally related to diabetes in Italian specialized centers.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments. A multicenter, prospective 1-year study.
- Published in:
- 2004
- By:
- Publication type:
- journal article